IN2013MU02046A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02046A
IN2013MU02046A IN2046MU2013A IN2013MU02046A IN 2013MU02046 A IN2013MU02046 A IN 2013MU02046A IN 2046MU2013 A IN2046MU2013 A IN 2046MU2013A IN 2013MU02046 A IN2013MU02046 A IN 2013MU02046A
Authority
IN
India
Prior art keywords
mscs
relates
treating
diabetes
isolation
Prior art date
Application number
Other languages
English (en)
Inventor
Satish Mahadeorao Totey
Manoj Kumar C Reddy
Lyle Carl Fonseca
Shashank Gowda
Aarya HARI
Basavaraj Chougule
Minita Sodhi
Original Assignee
Kasiak Res Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kasiak Res Pvt Ltd filed Critical Kasiak Res Pvt Ltd
Priority to IN2046MU2013 priority Critical patent/IN2013MU02046A/en
Priority to PCT/IN2013/000584 priority patent/WO2014203269A2/en
Publication of IN2013MU02046A publication Critical patent/IN2013MU02046A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN2046MU2013 2013-06-17 2013-09-26 IN2013MU02046A (https=)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN2046MU2013 IN2013MU02046A (https=) 2013-06-17 2013-09-26
PCT/IN2013/000584 WO2014203269A2 (en) 2013-06-17 2013-09-26 Method for isolation, purification and industrial scale expansion of canine adipose tissue derived mesenchymal stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2046MU2013 IN2013MU02046A (https=) 2013-06-17 2013-09-26

Publications (1)

Publication Number Publication Date
IN2013MU02046A true IN2013MU02046A (https=) 2015-06-05

Family

ID=52105424

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2046MU2013 IN2013MU02046A (https=) 2013-06-17 2013-09-26

Country Status (2)

Country Link
IN (1) IN2013MU02046A (https=)
WO (1) WO2014203269A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP1500218A2 (hu) * 2015-05-08 2016-11-28 Deltabio 2000 Kft Eljárás és készítmény ortopédiai betegségek, így ízületiporc-sérülések, különösen ízületi diszplázia kezelésére
CN105132500A (zh) * 2015-08-31 2015-12-09 李青峰 一种svf的制备方法
CN105238748A (zh) * 2015-10-27 2016-01-13 上海百众源生物科技有限公司 一种胎盘源壁蜕膜间充质干细胞分离冷冻的制备方法
CN105685015B (zh) * 2016-03-10 2018-11-27 广州赛莱拉干细胞科技股份有限公司 一种细胞冻存液
CN107746829B (zh) * 2017-10-19 2022-03-22 佛山科学技术学院 一种分离与原代培养犬胎盘来源的间充质干细胞的方法
WO2019175773A1 (en) 2018-03-12 2019-09-19 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
MA52883A (fr) * 2018-06-15 2021-05-26 Prieto Manuel Hermida Composition pharmaceutique pour dermatologie et ses utilisations
CN111621469A (zh) * 2020-06-01 2020-09-04 重庆医科大学 一种改良酶消化法分离骨细胞的技术及其应用
HU231475B1 (hu) * 2021-04-01 2024-02-28 Cellfactory Korlátolt Felelősségű Társaság Eljárás osteoartritisben szenvedő egyed kezelésére szolgáló készítmény előállítására
CN117897165A (zh) * 2021-07-08 2024-04-16 勃林格殷格翰比利时兽医公司 用于治疗特应性皮炎的间充质干细胞
CN113774020B (zh) * 2021-08-24 2023-04-14 河北朋和生物科技有限公司 一种脂肪间充质干细胞库的构建方法
BR102022016233A2 (pt) * 2022-08-16 2024-02-27 Omics Biotecnologia Animal Ltda Concentrado de proteínas e peptídeos derivados de células estromais mesenquimais, método de obtenção e uso de concentrado

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007035843A2 (en) * 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US8808688B2 (en) * 2009-10-06 2014-08-19 National University Corporation Nagoya University Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells
WO2011064733A1 (en) * 2009-11-27 2011-06-03 Stempeutics Research Pvt. Ltd. Methods of preparing mesenchymal stem cells, compositions and kit thereof
CA2788635A1 (en) * 2010-02-01 2011-08-04 The Board Of Trustees Of The Leland Stanford Junior University Enhanced efficiency of induced pluripotent stem cell generation
US20130129688A1 (en) * 2011-11-09 2013-05-23 Allocure, Inc. Assay for the Prediction of Therapeutic Effectiveness or Potency of Mesenchymal Stem Cells, and Methods of Using Same

Also Published As

Publication number Publication date
WO2014203269A2 (en) 2014-12-24
WO2014203269A3 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
IN2013MU02046A (https=)
IN2013MU02045A (https=)
BR112014029655A2 (pt) dispositivo para preparar tecido, e método para preparar tecido
MX383245B (es) Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
MX366422B (es) Proceso para preparar un producto lacteo fermentado colado.
MX391536B (es) Composicion y metodo para el diagnostico y tratamiento de enfermedades asociadas con la degeneracion de neuritas.
MX342200B (es) Método de tratamiento de células madre mesenquimales y su uso en el tratamiento de enfermedades asociadas a estrés oxidativo.
CR20120235A (es) Proceso para la preparación de calcobutrol
BR112015023472A2 (pt) método de produção de um produto químico, método de bioprodução de um produto químico, organismo geneticamente modificado e produto
BR112015006393A2 (pt) método para produzir um produto de tecido, produto de tecido produzido por um processo, e método de tratamento
MX2015015188A (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
BR122021023230B8 (pt) Vacina de combinação que compreende uma vacina compreendendo um parvovírus vivo atenuado
HUE068290T2 (hu) Eljárás 2-klór-1,1,2-tetrafluor-propán (HCFC-244bb) elõállítására
BR112016030758B8 (pt) Uso de células estromais multipotentes derivadas de tecido adiposo mesenquimal
ES2666382T8 (es) Ortesis activa para la rehabilitación neurológica del movimiento de los miembros inferiores, sistema que comprende dicha órtesis y proceso para poner en funcionamiento dicho sistema
MX2015008944A (es) Proceso de liofilizacion.
MX365351B (es) Harinas térmicamente inhibidas para mejorar la eficiencia de la esterilización en autoclave.
BR112016002317A2 (pt) métodos para aumentar o volume expiratório forçado em asmáticos usando benralizumab
BR112016002462A2 (pt) métodos para melhorar os sintomas da asma usando benralizumabe
BR112017018574A2 (pt) métodos para o tratamento de doenças
EP2919824A4 (en) METHOD OF NETWORKING BIOPROTHETIC TISSUE WITH BIOORTHOGONAL BINDING SAVINGS
IN2013MU02047A (https=)
MX2016012758A (es) Composicion hiperosmolar de acido hialuronico.
SG10202010615QA (en) Method for promoting and improving properties of adipose tissue, tissue and cells obtained by said method
PE20140631A1 (es) Producto en polvo de fosfato de celulosa y proceso para su elaboracion y aplicacion para eliminar contaminantes de soluciones acuosas